...
首页> 外文期刊>FEBS Letters >Inhibition of carcinogen‐induced cellular transformation of human fibroblasts by drugs that interact with the poly(ADP‐ribose) polymerase system
【24h】

Inhibition of carcinogen‐induced cellular transformation of human fibroblasts by drugs that interact with the poly(ADP‐ribose) polymerase system

机译:与聚(ADP-核糖)聚合酶系统相互作用的药物抑制致癌物诱导的人类成纤维细胞转化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

>Two types of interactions of 13 drugs with human fibroblasts were determined: (a) I 50 of nuclear poly(ADP-ribose) polymerase, as assayed with isolated nuclei in vitro, and (b) the non-toxic concentration of drugs that prevented carcinogen-induced cell transformation of intact fibroblasts (RCF1). In general, RCF1 was much lower than I 50, and one antitransformer did not inhibit the enzyme in vitro, indicating that low-affinity enzyme inhibitory sites appear to play no role in the mechanism of prevention of cell transformation. Two enzyme inhibitors, caffeine and 1-methylnicotinamide, exhibited no antitransforming activity. Benzamide when applied in population doubling 1 induced resistance to cell transformation in population doubling 6 by carcinogens added at this stage.
机译:>确定了13种药物与人成纤维细胞的两种相互作用:(a)核聚(ADP-核糖)聚合酶的 I 50 (b)防止致癌物诱导完整成纤维细胞转化的药物(RCF 1 )的无毒浓度。通常,RCF 1 远低于 I 50 ,并且一种抗转化剂在体外不抑制该酶,表明低亲和力酶抑制位点似乎在预防细胞转化的机制中不起作用。两种酶抑制剂,咖啡因和1-甲基烟酰胺,没有抗转化活性。在此阶段添加的致癌剂中,苯甲酰胺在种群加倍1中应用时诱导了对种群加倍6中细胞转化的抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号